Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04918095 · ClinicalTrials.gov registry record
CareCOPD - COPD Home Monitoring Study
A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by Cognita Labs.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04918095 is a study of Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by Cognita Labs. The registered enrollment target is 50 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04918095, a study of Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by Cognita Labs.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.
Conditions Studied
Interventions
- DEVICE CareCOPD Platform
Study Locations (1)
California
- Ventura County Medical Center - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2026-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04918095
The ClinicalTrials.gov registry entry for NCT04918095 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (97% lower). The listed sponsor is Cognita Labs, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which CareCOPD Platform is the first listed.
NCT04918095 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04918095 about?
NCT04918095 is a clinical study titled "CareCOPD - COPD Home Monitoring Study". This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.
What is the current status of trial NCT04918095?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2020-11-09. Estimated completion is 2026-07-31.
What conditions does trial NCT04918095 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT04918095?
The interventions under investigation include: CareCOPD Platform (DEVICE).
Who is sponsoring clinical trial NCT04918095?
This trial is sponsored by Cognita Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04918095 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RECRUITING
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
COPD Care Pathway Among Patients With Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.